🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY 1. Whether the early PEG-asp...
Status
Unknown
Location
Republican Research and Practical Center of Radiation Medicine
Start Date
2008-02
Trial ID
NCT01953770
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
This is a phase II study designed to investigate the combination of bortezo...
Status
Terminated
Location
Children's Mercy Hospital
Start Date
2015-07
Trial ID
NCT02535806
H. Lee Moffitt Cancer Center and Research Institute will be the Sunshine Pr...
Status
Completed
Location
Holtz Children's Hospital University of Miami Miller School of Medicine
Start Date
2011-07-18
Trial ID
NCT01324180
Treatments Being Tested
The purpose of this research study is to identify better ways to treat chil...
Status
Completed
Location
Jersey Shore University Medical Center
Start Date
2001-02
Trial ID
NCT00176462
Leukemia cells grow and divide fast and out of control. In normal cells, ce...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2018-04-20
Trial ID
NCT03515200
Randomized phase III trial to compare the effectiveness of different chemot...
Status
Completed
Location
Children's Oncology Group
Start Date
1996-08
Trial ID
NCT00002798
Treatment of pediatric acute lymphoblastic leukemia (ALL) has advanced and ...
Status
Unknown
Location
Seoul National University, College of Medicine
Start Date
2015-01
Trial ID
NCT02339350
Treatments Being Tested